ctDNA Predicts Pain Response in a Multi-Institutional Phase II Trial of Palliative Radiation, Palbociclib and Hormone Therapy in Metastatic Breast Cancer

被引：0
|
作者：
Torres, M. [1 ]
Friend, S. [2 ]
Niemierko, A. [3 ]
Lin, J. Y. [1 ]
Iafrate, A. [3 ]
Xiao, C. [4 ]
Kahn, S. T. [5 ]
Godette, K. D. [6 ]
Hanasoge, S. [5 ]
Yu, D. S. [6 ]
Eng, T. Y. [5 ]
Cheney, M. D. [7 ]
Wiggers, N. [8 ]
Pippas, A. [9 ]
Goginini, K.
Meisel, J. [10 ]
Schuster, D. M. [11 ]
Bardia, A. [12 ]
Miller, A. H. [13 ]
Felger, J.
Switchenko, J. [14 ]
Zelnak, A. [15 ]
Kalinsky, K. [16 ]
Daniels, T. [2 ]
Medford, A. [3 ]
Bhave, M. [17 ]
机构：
[1] Emory Univ, Glenn Family Breast Ctr, Winship Canc Inst, Atlanta, GA USA
[2] Emory Univ, Sch Med, Atlanta, GA USA
[3] Massachusetts Gen Hosp, Boston, MA USA
[4] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA USA
[5] Emory Univ, Dept Radiat Oncol, Winship Canc Inst, Atlanta, GA USA
[6] Emory Univ, Winship Canc Inst, Dept Radiat Oncol, Atlanta, GA USA
[7] Spectrum Healthcare Partners, Portland, ME USA
[8] Northside Hosp, Atlanta, GA USA
[9] Piedmont Columbus Reg, John B. Amos Canc Ctr, Columbus, GA USA
[10] Emory Univ, Winship Canc Inst, Dept Med Oncol, Atlanta, GA USA
[11] Emory Univ, Dept Radiol & Imaging Sci, Atlanta, GA USA
[12] UCLA, Los Angeles, CA USA
[13] Emory Univ, Sch Medi, Dept Psychiat & Behav Sci, Atlanta, GA USA
[14] Emory Univ, Atlanta, GA USA
[15] Northside Hosp, Atlanta Canc Care, Atlanta, GA USA
[16] Emory Winship Canc Inst, Atlanta, GA USA
[17] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1037
引用
收藏
页码：S164 / S164
页数：1
相关论文
共 50 条
  • [31] A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer
    Kim, Edward J.
    Ben-Josef, Edgar
    Herman, Joseph M.
    Bekaii-Saab, Tanios
    Dawson, Laura A.
    Griffith, Kent A.
    Francis, Isaac R.
    Greenson, Joel K.
    Simeone, Diane M.
    Lawrence, Theodore S.
    Laheru, Daniel
    Wolfgang, Christopher L.
    Williams, Terence
    Bloomston, Mark
    Moore, Malcolm J.
    Wei, Alice
    Zalupski, Mark M.
    CANCER, 2013, 119 (15) : 2692 - 2700
  • [32] Impact of radiation therapy on breast-conserving therapy for breast cancer in Japanese women: A retrospective analyses of multi-institutional experience. Kansai Breast Cancer Radiation Therapy Study Group
    Mitsumori, Michihide
    Hiraoka, Masahiro
    Inaji, Hideo
    Noguchi, Shinzaburo
    Oishi, Hajime
    Kodama, Hiroshi
    Koyama, Hiroki
    ONCOLOGY REPORTS, 2009, 21 (06) : 1461 - 1466
  • [33] ESR1 mutations evolve during the treatment of metastatic breast cancer, and detection in ctDNA predicts sensitivity to subsequent hormone therapy
    Schiavon, Gaia
    Hrebien, Sarah
    Garcia-Murillas, Isaac
    Pearson, Alex
    Tarazona, Noelia
    Lopez-Knowles, Elena
    Ribas, Ricardo
    Nerurkar, Ashutosh
    Osin, Peter
    Martin, Lesley-Ann
    Dowsett, Mitch
    Smith, Ian E.
    Turner, Nicholas C.
    CANCER RESEARCH, 2015, 75
  • [34] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase-II trial
    Deraco, Marcello
    Kusamura, Shigeki
    Virzi, Salvatore
    Puccio, Francesco
    Macri, Antonio
    Famulari, Ciro
    Solazzo, Massimiliano
    Bonomi, Serena
    Iusco, Domenico Rosario
    Baratti, Dario
    GYNECOLOGIC ONCOLOGY, 2011, 122 (02) : 215 - 220
  • [35] A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck
    Nathan, Cherie-Ann O.
    Hayes, D. Neil
    Karrison, Theodore
    Harismendy, Olivier
    Flores, Jose M.
    Moore-Medlin, Tara
    Vokes, Everett E.
    Gutkind, J. Silvio
    Neupane, Prakash
    Mills, Glenn
    Sargi, Zoukaa
    Seiwert, Tanguy
    Grilley-Olson, Juneko
    Day, Terry
    Gillison, Maura
    Wade, James L.
    Feldman, Lawrence
    Jha, Gautam
    Kozloff, Mark
    O'Leary, Miriam
    Worden, Francis P.
    Cohen, Ezra E. W.
    CLINICAL CANCER RESEARCH, 2022, 28 (23) : 5040 - 5048
  • [36] Focus On Adaptive Treatments For The First Multi-Institutional Online Adaptive Radiation Therapy Trial (SMART) in Pancreas Cancer
    Kim, J.
    Bassetti, M. F.
    Raldow, A.
    Low, D.
    Lee, P.
    Green, O. L.
    Chuong, M. D.
    Parikh, P. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E575 - E576
  • [37] A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer
    Barroso-Sousa, Romualdo
    Krop, Ian E.
    Trippa, Lorenzo
    Tan-Wasielewski, Zhenying
    Li, Tianyu
    Osmani, Wafa
    Andrews, Chelsea
    Dillon, Deborah
    Richardson, Edward T., III
    Pastorello, Ricardo G.
    Winer, Eric P.
    Mittendorf, Elizabeth A.
    Bellon, Jennifer R.
    Schoenfeld, Jonathan D.
    Tolaney, Sara M.
    CLINICAL BREAST CANCER, 2020, 20 (03) : 238 - 245
  • [38] A phase II trial investigating if bevacizumab in combination with hormone therapy will reverse acquired estrogen independence in metastatic breast cancer patients
    Falkson, C.
    Rossman, J. F.
    Nabell, L.
    Carpenter, J.
    Saleh, M. N.
    O'Malley, J.
    Forero, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [39] Impact of radiation therapy for breast cancer with involved surgical margin after immediate breast reconstruction: A multi-institutional observational study
    Sasada, Shinsuke
    Nagura, Naomi
    Shimo, Ayaka
    Ogiya, Akiko
    Saiga, Miho
    Seki, Hirohito
    Mori, Hiroki
    Kondo, Naoto
    Ishitobi, Makoto
    Narui, Kazutaka
    Nogi, Hiroko
    Yamauchi, Chikako
    Sakurai, Teruhisa
    Shien, Tadahiko
    EJSO, 2024, 50 (06):
  • [40] Phase I/II clinical trial of gene therapy for hormone refractory metastatic prostate cancer
    Gotoh, A
    Terao, S
    Shirakawa, T
    JOURNAL OF GENE MEDICINE, 2006, 8 (03): : 371 - 372
12345